EFLORNITHINE for Neuroblastoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where EFLORNITHINE was used for Neuroblastoma.
Most Reported Side Effects for EFLORNITHINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 127 | 41.4% | 0 | 1 |
| Hair growth abnormal | 29 | 9.5% | 0 | 1 |
| Rash | 20 | 6.5% | 0 | 1 |
| Alopecia | 18 | 5.9% | 0 | 0 |
| Off label use | 17 | 5.5% | 0 | 0 |
| Product availability issue | 14 | 4.6% | 0 | 0 |
| Therapeutic response decreased | 13 | 4.2% | 0 | 0 |
| Drug dose omission | 12 | 3.9% | 0 | 0 |
| Application site erythema | 10 | 3.3% | 0 | 0 |
| Incorrect dose administered | 9 | 2.9% | 0 | 0 |
| Application site pain | 8 | 2.6% | 0 | 0 |
| Product quality issue | 8 | 2.6% | 0 | 0 |
| Death | 7 | 2.3% | 7 | 0 |
| Erythema | 7 | 2.3% | 0 | 0 |
| Expired product administered | 7 | 2.3% | 0 | 0 |
Other Indications for EFLORNITHINE
Hair growth abnormal (145)
Product used for unknown indication (78)
Hypertrichosis (13)
Hirsutism (10)
Hypotrichosis (6)
Other Drugs Used for Neuroblastoma
CYCLOPHOSPHAMIDE (1,109)
ETOPOSIDE (1,061)
DOXORUBICIN (725)
CARBOPLATIN (671)
VINCRISTINE (668)
CISPLATIN (633)
MELPHALAN (495)
TOPOTECAN (443)
DINUTUXIMAB (354)
BUSULFAN (252)